Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome (NCT07190768) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome
100 participantsStarted 2025-10-01
Plain-language summary
This study aims to compare the effectiveness of two common physiotherapy methods, Kinesiologic Taping (KT) and Dry Needling (DN), in the treatment of Subacromial Pain Syndrome (SAPS), a frequent cause of shoulder pain. The trial also investigates whether using KT and DN together provides greater benefits than using them separately. The main goal is to determine which treatment approach is more effective in reducing pain and improving shoulder function in patients with SAPS.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Age 18-65 years
Pain in the upper, outer arm, especially during shoulder elevation
Shoulder pain lasting more than 6 weeks with or without partial rotator cuff tear
At least three of the following findings:
Painful arc during flexion or abduction
Positive Neer test
Positive Hawkins-Kennedy test
Painful resisted external rotation
Positive Jobe's test
Diagnosis confirmed by MRI evaluation when indicated
Exclusion Criteria:
Participation in a physical therapy program or receipt of injection therapy within the past 3 months
Previous shoulder surgery
Presence of joint contracture
Complete tendon rupture
Cervical radiculopathy
Systemic inflammatory disease (e.g., rheumatoid arthritis, ankylosing spondylitis)
Known allergy to tape or materials used in interventions
Bleeding disorders
Local infection or open wound in the treatment area
Cognitive dysfunction that prevents cooperation
History of malignancy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain intensity (Visual Analogue Scale, VAS)
Timeframe: Baseline, immediately after first treatment, 1 week after first treatment, and at the end of week 3.